J. Eric Evans
Teladoc HealthAbout J. Eric Evans
Independent director since September 2023; age 48. Evans is Chief Executive Officer of Surgery Partners, Inc., and serves on Teladoc Health’s Audit Committee, chairs the Compensation Committee, and is a member of the Executive Committee. He holds an MBA from Harvard Business School and a bachelor’s degree in Industrial Management from Purdue University. The Board cites his executive leadership and extensive healthcare industry experience as core credentials supporting his appointment and committee roles .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Surgery Partners, Inc. | Chief Executive Officer and Director | 2020–present | Led strategic and operational transformation in surgical services |
| Surgery Partners, Inc. | EVP & Chief Operating Officer | 2019–2020 | Oversight of enterprise operations |
| Tenet Healthcare Corporation | President, Hospital Operations | 2016–2018 | Led hospital operations across Tenet’s portfolio |
| Tenet Healthcare Corporation | CEO, former Texas region | 2015–2016 | Regional leadership; hospital performance execution |
| The Hospitals of Providence (El Paso) | Market CEO | 2012–2015 | Market leadership for care delivery and operations |
External Roles
| Organization | Role | Public/Private/Non-profit | Notes |
|---|---|---|---|
| Surgery Partners, Inc. | CEO and Director | Public | Current public company board service |
| QuVa Pharma | Director/Advisor (engagement) | Private | Governance/industry engagement |
| SPOON Foundation | Director/Advisor (engagement) | Non-profit | Philanthropic involvement |
| American Heart Association of Middle Tennessee | Director/Advisor (engagement) | Non-profit | Community health engagement |
| Nashville Health Care Council | Member/Advisor | Non-profit | Industry leadership network |
Board Governance
- Committee assignments and independence:
- Compensation Committee Chair; members: Evans (Chair), Thomas G. McKinley, David L. Shedlarz, David B. Snow, Jr.; all independent; 11 meetings in FY2024 .
- Audit Committee member; Chair: David L. Shedlarz; members include Evans and Catherine A. Jacobson, Thomas G. McKinley; all independent; 6 meetings in FY2024 .
- Executive Committee member; Chair: David B. Snow, Jr.; members include Evans, Kenneth H. Paulus, David L. Shedlarz, Mark D. Smith; all independent; 6 meetings in FY2024 .
- Governance structure: Independent Board Chair (David B. Snow, Jr.); separate CEO (Charles Divita, III). Regular executive sessions of independent directors; majority voting in uncontested elections .
- Independence and engagement: Eight of nine director nominees are independent under NYSE rules; all current directors attended at least 75% of 2024 board and relevant committee meetings they served on (Board held 13 meetings; committees: Audit 6, Compensation 11, NCGC 8, Quality of Care and Patient Safety 4, Executive 6) .
Fixed Compensation
| Director | 2024 Cash Fees ($) | 2024 Stock Awards ($) | 2024 Total ($) |
|---|---|---|---|
| J. Eric Evans | 66,099 | 199,997 | 266,096 |
Program structure for non-employee directors:
- Board annual retainer: $45,000; Committee chair retainers: Audit $20,000, Compensation $20,000, NCGC $10,000, QCPSC $10,000; Committee member retainers: Audit $10,000, Compensation $7,500, NCGC $5,000, QCPSC $5,000; annual equity grant (RSUs): $200,000; initial RSU grant: $250,000. Executive Committee has no additional compensation .
Performance Compensation
| Component | Detail |
|---|---|
| Performance-based pay elements for directors | None disclosed; director equity grants are time-based RSUs under the Non-Employee Director Compensation Program . |
Other Directorships & Interlocks
| External Company | Relationship to TDOC | Related-Party Transactions Disclosed |
|---|---|---|
| Surgery Partners, Inc. | No direct TDOC transaction disclosed | None involving Evans; Audit Committee reviews RPTs; only disclosed RPT in 2024 was with Cedar Gate Technologies (CEO and 10% owner is TDOC Board Chair David B. Snow, Jr.), total contract approx. $6.3M over 3 years; $517,250 paid in 2024 . |
- Independence safeguards: All related-party transactions are reviewed and approved by the Audit Committee; directors cannot participate in approvals where they are a related party .
Expertise & Qualifications
- Executive leadership across provider and surgical services (Surgery Partners CEO; Tenet hospital operations leadership); healthcare operations and strategic planning expertise. Education: MBA (Harvard), bachelor’s in Industrial Management (Purdue). Board explicitly cites his executive leadership and healthcare industry knowledge as qualifications .
Equity Ownership
| Holder | Shares Owned | Options (exercisable within 60 days) | RSUs (vest within 60 days) | Notable Notes | Percent of Class |
|---|---|---|---|---|---|
| J. Eric Evans | 6,097 | — | — | Excludes 17,467 RSUs deferred under the Director Deferred Compensation Plan | <1% |
- Director equity holdings as of Dec 31, 2024: Evans held 24,581 stock awards (no options) per the director holdings table .
- Stock ownership guidelines: Non-employee directors must hold ≥3× annual Board cash retainer; TDOC prohibits hedging and pledging of company stock by directors under its insider trading policy .
Governance Assessment
- Strengths:
- Independent director with relevant operating expertise; serves as Compensation Committee Chair and on Audit and Executive Committees, supporting board effectiveness in pay oversight, financial stewardship, and urgent matters .
- Robust governance framework: independent chair; regular executive sessions; majority voting; strong committee independence; audit committee financial experts in place .
- Alignment mechanisms: time-based RSUs, director stock ownership guidelines; prohibition on hedging/pledging; clawback policy adopted per SEC/NYSE rules .
- Shareholder support signals: Say-on-Pay approval 91.6% (2022), 81.9% (2023), 95.9% (2024) .
- Watch items:
- Time commitments: Evans is a sitting public-company CEO (Surgery Partners) while chairing TDOC’s Compensation Committee and serving on two other TDOC committees; TDOC discloses “no overboarding,” but ongoing monitoring of workload and attendance remains prudent .
- Related-party oversight at board level: While no Evans-related RPTs disclosed, TDOC’s 2024 RPT with Cedar Gate (Board Chair’s company) is a governance sensitivity; Audit Committee oversight and disclosure mitigations are in place .